Letters 133 generation only. When the body is facing a high-fat challenge such as in obesity or high-fat feeding, the expression of UCP-2 could serve as a means to discharge fat-associated energy by not only enhancing proton leak but also transforming fuel configuration which is achieved by stimulating gluconeogenesis. As such, a loop between fat and glucose metabolism is formed (Fig. 1) . To further elucidate the 'bona fide' role of UCP-2 in hepatocytes, a tissue-specific knockout strategy rather than global null-mouse model is suggested since transgenic studies have shown that phenotypes resulting from global knockout model tends to be confounded by in vivo compensation mechanism whereas tissue specific disruption of the UCP-2 gene could reveal its natural attribute.
. The emerged significance of UCP-2 expression in the liver. The solid line is the pathway that has been established, whereas the dashed line is the pathway that needs further confirmation.
• • -represents enhancement, ⊕ represents inhibition. ATP depletion serves as the link between UCP-2 activity and AMPK signalling system. The overall scheme suggests a metabolic flux from increased fat availability to enhanced gluco- 
Authors' reply
To the Editor: It is an author's reward when one's published findings, opinions or speculations generate debate, corroboration and/or enthusiasm within a field. Indeed, there have been some new and intriguing findings regarding the potential role of uncoupling protein-2 in the liver since our manuscript was submitted for publication. Initial studies showed a noticeable lack of uncoupling protein-2 in normal rat hepatocytes except under certain metabolic conditions. Instead, ucp2 gene expression in the liver appeared to be limited to non-parenchymal cells with a noticeable predominance in Kupffer cells [1] . More recently, demonstrable levels of ucp2 mRNA have been described in cultured rat hepatocytes [2] . Moreover, the authors demonstrated a more profound up-regulation of ucp2 gene expression in rat hepatocytes by polyunsaturated fatty acids with both monounsaturated and saturated fatty acids eliciting more modest increases in ucp2 mRNA levels [2] . In addition, it is proposed that the up-regulation of ucp2 gene expression in response to polyunsaturated fatty acids could be mediated through a prostaglandin signalling pathway in which peroxisome proliferator-activated receptor-α could be activated. While the evidence supporting the proposed regulation of ucp2 gene expression by peroxisome proliferator-activated receptor-α is convincing, there remains some uncertainty as to the significance of this effect in the liver. A recent finding by Nakatani et al. [3] indicates that activation of peroxisome proliferator-activated receptor-α increases ucp2 gene transcription rather than enhancing ucp2 mRNA stability in rodent hepatocytes. Those authors suggest that ucp2 gene expression might not be as responsive to reactive oxygen species production as was first thought.
Very little is known about the possible contribution of uncoupling protein-2 to fuel metabolism in liver cells. Given that the liver plays an integral role in nutrient partitioning and is central to several pathways including lipolysis, lipogenesis, glycolysis and gluconeogenesis, and in light of a proposed role for uncoupling protein-2 in lipid and glucose metabolism in other tissues, it is conceivable that uncoupling protein-2 in hepatocytes could contribute to metabolic homeostasis. We find the proposed connection between uncoupling protein-2-induced ATP depletion and 5′-AMP-activated protein kinase activation, and yet further, gluconeogenesis within hepatocytes, to be thought-provoking and insightful. If such a pathway does exist, it is likely to be operative only under specific metabolic conditions. In ob/ob mice, a model for non-alcoholic fatty liver disease in which increased uncoupling protein-2 has been documented [4, 5] , phosphoenolpyruvate carboxykinase is found to be reduced [6] , seemingly ruling out a straight-forward relation between uncoupling protein-2 and gluconeogenesis even in a mildly diabetic animal such as the obese mouse. As the author, himself, acknowledges it has yet to be proven that the proposed cascade of events does in fact occur and we await with much interest the findings of those studies. . These findings, together with potential effects on glucose homeostasis, makes ghrelin a potentially important player in the pathophysiology of Type 2 diabetes. Healthy offspring of Type 2 diabetic patients have often been considered a model of studying the early metabolic aberrations in the development of Type 2 diabetes. We sought to determine the involvement of ghrelin in the possible development of Type 2 diabetes by comparing fasting circulating concentrations of ghrelin in 23 healthy but insulin resistant first degree relatives of Type 2 diabetic patients, and 16 healthy control subjects matched by age, sex, and BMI. All gave written consent to participate and the study was approved by the local ethics committee of the county of Aarhus and conducted in accordance with the guidelines proposed in the Declaration of Helsinki.
All subjects were examined by measuring anthropometric variables, body-composition, fasting samples of plasma ghrelin, and an OGTT (75 g). On a subsequent day, a 150 min hyperinsulinaemic (0.6 mU·kg -1 ·min -1 ) euglycaemic clamp was carried out to assess insulin-stimulated glucose uptake (M-value).
Plasma samples were collected in tubes with aprotinin/ EDTA solution in an ice bath and frozen immediately and kept at -80°C. Total plasma ghrelin was measured with a radioimmunoassay as described previously [5] . Plasma glucose was measured immediately after sampling (Beckman Instruments, Palo Alto, Calif., USA). Serum insulin was determined by ELISA, and body composition was evaluated by dual energy X-ray absorptiometry.
Data are given as means±SD or geometric mean and range, as appropriate. Student's two-tailed t test for unpaired data was used for comparison of data between groups. Correlations were examined using Pearson's correlation analysis. Furthermore, data were analysed by using multivariate linear regression analysis with ghrelin as the dependent variable. Due to the graphical impression of a curvilinear relation between insulin and ghrelin, an exponential model was applied. All statistical analyses were done by using SPSS for Windows version 10.0 (SPSS, Chicago), and a p value of less than 0.05 was considered statistically significant.
The offspring group was insulin-resistant compared to the control group (M-value; 4.52±1.87 vs. 6.45±2.77 mg·kg -1 · min -1 , p<0.05). Fasting plasma glucose (5.1±0.5 vs. 4.8±0.4 mmol/l, p<0.05) and 120 min plasma glucose (5.9±0.9 vs. 4.6± 1.1 mmol/l, p<0.001) were increased in the offspring group. However, all had a normal OGTT. Whereas fasting concentrations of serum insulin did not differ between groups [34.0 (14.0-100.5) vs 29.1 (16.0-66.0) pmol/l, p=0.24], mean serum insulin concentrations [194.8 (83.9-788.4) vs 145.4 (69.4-244 .7) pmol/l, p=0.05], as well as area under the curve of serum insulin during the 180 min pmol·l -1 ·3h -1 , p=0.05), were higher in the offspring group. Men and women were comparable with respect to age, BMI, and insulinaemia, but, as expected, women were characterized by an increased body fat content.
Fasting plasma ghrelin was substantially (~25%) reduced in the offspring group [138.0 (55.9-237.0) vs 183.3 (97.0-287.7)
